Clinical trial
A Prospective Study Evaluating the Efficacy of ActiGraft in Secondary Closure of Abdominal Surgical Wound Dehiscence
NCT04899466 is registered in ClinicalTrials.gov with RedDress Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Study Evaluating the Efficacy of ActiGraft in Secondary Closure of Abdominal Surgical Wound Dehiscence
- Lead sponsor
- RedDress Ltd.
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- August 1, 2021
- Completion date
- August 1, 2026
- Enrollment
- 20 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
dehiscence wound